Prakt. lékáren. 2016; 12(3): 90-92 | DOI: 10.36290/lek.2016.020

Effect of myo-inositol on the development of oocytes and embryos

Pavel Trávník
REPROMEDA s. r. o., Brno

The results of many studies have indicated the benefit of using myo-inositol in reproductive medicine. Besides the classical

application in patients with polycystic ovary syndrome, myo-inositol is also effective in the preparation of women for natural

conception and for extracorporeal fertilization.

Keywords: reproductive medicine, myo-inositol, inositol, chiro-inositol, ovarian stimulation, conception preparation

Published: July 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Trávník P. Effect of myo-inositol on the development of oocytes and embryos. Pharmacy for Practice. 2016;12(3):90-92. doi: 10.36290/lek.2016.020.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Trávník P. Moderní tendence ve stimulaci ovarií. Prakt lékáren. 2015; 11(4): 123-125.
    2. Huang LC, Fonteles MC, Houston DB, Zhang C, Larner J. Chiro inositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology. 1993; 132(2): 652-657. Go to original source... Go to PubMed...
    3. Di Paolo G, De Camilli P. Phosphoinositides in cell regulation and membrane dynamics. Nature 2006; 443: 651-657. Go to original source... Go to PubMed...
    4. Downes CP, Macphee CH. myo-inositol metabolites as cellular signals. Eur J Biochem 1990; 193: 1-18. Go to original source... Go to PubMed...
    5. Beemster P, Groenen P, Steegers-Theunissen R. Involvement of inositol in reproduction. Nutr Rev 2002; 60: 80-87. Go to original source... Go to PubMed...
    6. Bevilacqua A, Carlomagno G, Gerli S, Montanino Oliva M, Devroey P, Lanzone A, Soulange C, Facchinetti F, Carlo Di Renzo G, Bizzarri M, Hod M, Cavalli P, D'Anna R, Benvenga S, Chiu TT, Kamenov ZA. Results from the International Consensus Conference on myo-inositol and D-chiro-inositol in Obstetrics and Gynecology-assisted reproduction technology. Gynecol Endocrinol. 2015; 31(6): 441-446. Go to original source... Go to PubMed...
    7. Chaudhary K, Babu KN, Joshi VN, Srivastava S, Chakravarty BN. NMR-based metabolomics reveals differently expressed metabolites in follicular fluid of PCOS women:potential biomarkers for good quality oocyte? Hum Reprod 2011; 26: i226-i246.
    8. Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF:relationship with oocyte quality. Hum Reprod. 2002; 17(6): 1591-1596. Go to original source... Go to PubMed...
    9. Goud PT, Goud AP, Van Oostveldt P, Dhont M. Presence and dynamic redistribution of type I inositol 1,4,5-trisphosphate receptors in human oocytes and embryos during in-vitro maturation, fertilization and early cleavage divisions. Mol Hum Reprod 1999; 5: 441-451. Go to original source... Go to PubMed...
    10. Sobinoff AP, Sutherland JM, Mclaughlin EA. Intracellular signalling during female gametogenesis. Mol Human Reprod 2013; 19(5): 265-278. Go to original source... Go to PubMed...
    11. Křepelka P. Myo-inositol v terapii syndromu polycystických ovarií. Čes Gynek 2014; 79(3): 242-246.
    12. Homburg R. Polycystic ovary syndrome - from gynaecological curiosity to multisystem endocrinopathy. Hum Reprod 1996; 11: 29-39. Go to original source... Go to PubMed...
    13. Unfer V, Carlomagno G, Rizzo P, Raffone E, Roseff S. Myo-inositol rather than D-chiro-inositol is able to improve oocyte quality in intracytoplasmic sperm injection cycles. A prospective, controlled, randomized trial. Eur Rev Med Pharmacol Sci 2011; 15(4): 452-457. Go to PubMed...
    14. Ciotta L, Stracquadanio M, Pagano I, Carbonaro A, Palumbo M, Gulino F. Effects of myo-inositol supplementation on oocyte's quality in PCOS patients:a double blind trial. Eur Rev Med Pharmacol Sci 2011; 15(5): 509-514. Go to PubMed...
    15. Lisi F, Carfagna P, Oliva MM, Rago R, Lisi R, Poverini R, Manna C, Vaquero E, Caserta D, Raparelli V, Marci R, Moscarini M. Pretreatment with myo-inositol in non polycystic ovary syndrome patients undergoing multiple follicular stimulation for IVF:a pilot study. Reprod Biol Endocrinol 2012; 10: 52. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.